AU2001278001A1 - Agonist of follicle stimulating hormone activity - Google Patents
Agonist of follicle stimulating hormone activityInfo
- Publication number
- AU2001278001A1 AU2001278001A1 AU2001278001A AU7800101A AU2001278001A1 AU 2001278001 A1 AU2001278001 A1 AU 2001278001A1 AU 2001278001 A AU2001278001 A AU 2001278001A AU 7800101 A AU7800101 A AU 7800101A AU 2001278001 A1 AU2001278001 A1 AU 2001278001A1
- Authority
- AU
- Australia
- Prior art keywords
- agonist
- stimulating hormone
- follicle stimulating
- hormone activity
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 title 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 229940028334 follicle stimulating hormone Drugs 0.000 title 1
- 230000003054 hormonal effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09629180 | 2000-07-31 | ||
| US09/629,180 US6426357B1 (en) | 1999-07-27 | 2000-07-31 | Antagonists of follicle stimulating hormone activity |
| PCT/US2001/023386 WO2002009705A2 (en) | 2000-07-31 | 2001-07-24 | Agonist of follicle stimulating hormone activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001278001A1 true AU2001278001A1 (en) | 2002-02-13 |
Family
ID=24521931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001278001A Abandoned AU2001278001A1 (en) | 2000-07-31 | 2001-07-24 | Agonist of follicle stimulating hormone activity |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6426357B1 (en) |
| EP (1) | EP1315489A1 (en) |
| JP (1) | JP2004505050A (en) |
| AU (1) | AU2001278001A1 (en) |
| CA (1) | CA2426297A1 (en) |
| WO (1) | WO2002009705A2 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7754722B2 (en) * | 2002-09-20 | 2010-07-13 | Merck Serono Sa | Piperazine derivatives and methods of use |
| WO2006039400A2 (en) | 2004-09-29 | 2006-04-13 | Mount Sinai School Of Medicine Of New York University | Fsh and fsh receptor modulator compositions and methods for inhibiting osteoclastic bone resorption and bone loss in osteoporosis |
| US7691848B2 (en) * | 2005-03-02 | 2010-04-06 | Wyeth | Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists |
| JP2008540564A (en) * | 2005-05-12 | 2008-11-20 | ワイス | Pyrrolobenzodiazepine, heteroaryl, aryl and cycloalkylaminoketone derivatives as follicle stimulating hormone receptor (FSH-R) antagonists |
| MX2007014085A (en) * | 2005-05-12 | 2008-02-07 | Wyeth Corp | Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (fsh-r) antagonists. |
| WO2006135687A1 (en) * | 2005-06-09 | 2006-12-21 | Wyeth | Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists |
| AU2007254165A1 (en) * | 2006-05-17 | 2007-11-29 | Forschungsverbund Berlin E.V. | Pyrimidine low molecular weight ligands for modulating hormone receptors |
| EP1932831A1 (en) * | 2006-12-13 | 2008-06-18 | Bayer Schering Pharma Aktiengesellschaft | 1,2-Diarylacetylene Derivatives of Acyltryptophanols |
| US20080221195A1 (en) * | 2006-12-13 | 2008-09-11 | Lars Wortmann | 1,2-diarylacetylene derivatives of acyltryptophanols |
| EP1956016A1 (en) * | 2006-12-15 | 2008-08-13 | Bayer Schering Pharma Aktiengesellschaft | Bicyclic acyltryptophanols |
| US20080207728A1 (en) * | 2006-12-15 | 2008-08-28 | Lars Wortmann | Bicyclic acyltryptophanols |
| WO2008071455A1 (en) * | 2006-12-15 | 2008-06-19 | Bayer Schering Pharma Aktiengesellschaft | Bicyclic acyltryptophanols |
| EP2090322A1 (en) | 2008-02-18 | 2009-08-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of fsh receptor ligands for diagnosis and therapy of cancer |
| US20110190201A1 (en) * | 2008-07-24 | 2011-08-04 | Searete Llc | Method, device, and kit for maintaining physiological levels of steroid hormone in a subject |
| US20100022494A1 (en) * | 2008-07-24 | 2010-01-28 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method, device, and kit for maintaining physiological levels of steroid hormone in a subject |
| US20100022991A1 (en) * | 2008-07-24 | 2010-01-28 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | System and device for maintaining physiological levels of steroid hormone in a subject |
| US20100022497A1 (en) * | 2008-07-24 | 2010-01-28 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject |
| US20100061976A1 (en) * | 2008-07-24 | 2010-03-11 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject |
| BR112014019351A8 (en) | 2012-02-08 | 2017-07-11 | Merck Patent Gmbh | DEUTERATED THIAZOLIDINONE ANALOGS AS AGONISTS FOR FOLLICLE STIMULATING HORMONE RECEPTOR |
| US10308597B2 (en) | 2014-04-30 | 2019-06-04 | Rgenix, Inc. | Inhibitors of creatine transport and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5032588A (en) * | 1989-12-08 | 1991-07-16 | Abbott Laboratories | Thiazole lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids |
-
2000
- 2000-07-31 US US09/629,180 patent/US6426357B1/en not_active Expired - Fee Related
-
2001
- 2001-07-24 AU AU2001278001A patent/AU2001278001A1/en not_active Abandoned
- 2001-07-24 CA CA002426297A patent/CA2426297A1/en not_active Abandoned
- 2001-07-24 JP JP2002515258A patent/JP2004505050A/en active Pending
- 2001-07-24 WO PCT/US2001/023386 patent/WO2002009705A2/en not_active Ceased
- 2001-07-24 EP EP01955953A patent/EP1315489A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004505050A (en) | 2004-02-19 |
| WO2002009705A2 (en) | 2002-02-07 |
| US6426357B1 (en) | 2002-07-30 |
| CA2426297A1 (en) | 2002-02-07 |
| EP1315489A1 (en) | 2003-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001278006A1 (en) | Agonists of follicle stimulating hormone activity | |
| AU2001278001A1 (en) | Agonist of follicle stimulating hormone activity | |
| AU2001231531A1 (en) | Follicle stimulating hormones | |
| AU2003207775A1 (en) | Long-acting follicle stimulating hormone analogues and uses thereof | |
| AU5963900A (en) | Muteins of bilin-binding protein | |
| AU7315700A (en) | Melanin concentrating hormone antagonist | |
| AU2002230860A1 (en) | Skin desinfectant applicator | |
| AU2002232544A1 (en) | Skin disinfectant applicator | |
| AU2002229087A1 (en) | Skin disinfectant applicator | |
| AU3867400A (en) | Methods of using bioelastomers | |
| AU4996300A (en) | Method of electroporation-enhanced delivery of active agents | |
| AU6934600A (en) | Cd40 ligand and cd40 agonist compositions and methods of use | |
| AU2001227815A1 (en) | Chemically specific imaging of tissue | |
| EP1153602A4 (en) | Skin preparations for external use | |
| AU4134101A (en) | Hormone receptor functional entities and methods of their use | |
| AU2002302544A1 (en) | Active ingredient combinations for hair-dyeing agents | |
| AU7599200A (en) | Fractal analysis of time varying data | |
| AU3622600A (en) | Metalloproteinases and methods of use therefor | |
| EP1450860A4 (en) | Animal feeds including actives and methods of using same | |
| AU4834900A (en) | Antagonists of gonadotropin releasing hormone | |
| AU2001272383A1 (en) | Fungicidal combinations of active agents | |
| WO2001091700A8 (en) | Composition and method for enhancing elasticity of tissue | |
| AU2001275707A1 (en) | Use of panaxatriol for stimulation angiogenesis | |
| AU3212500A (en) | Grooming device and method of using | |
| AU3047299A (en) | Methods of delivering glp-1 |